Marijuana can’t cure the eye disease, but it can help delay its progression and treat its symptoms
Age-related macular degeneration (AMD) is an eye disease that can cloud central vision. It occurs when aging damages the macula, the part of the eye that controls sharp, front vision. Given that many people today use cannabis to treat glaucoma, it is possible that cannabis may also be effective for this type of condition.
Medical cannabis and cannabidiol (CBD)-rich alternatives for AMD are increasingly gaining ground in mainstream medicine. Thanks to a large number of beneficial effects on health, CBD is presented as a very viable alternative for the management of different conditions and diseases, among which its effects on this condition stand out.
People with AMD usually suffer from depression and anxiety, and it is already known that cannabis is ideal for treating these mental illnesses and providing a better quality of life for these patients. Cannabis also has a wide range of effects because endocannabinoid receptors seem to affect a variety of parts of the body, including the eyes.
Cannabis-based treatment for ADM is based on lowering the [intraocular] pressure inside the eyeball. The thing about medical cannabis is that one of its many virtues is to lower this pressure, which helps both glaucoma and AMD.
Studies have also found that different people who consume cannabis have been significantly less likely to develop AMD than those who have never consumed the plant. While there is no conclusive data yet, cannabis is on its way to becoming one of the most sought-after alternatives for treating various eye infections.